On July 3,  Scitop Bio, a high-tech enterprise of food additives and probiotic products, achieved its A-share issuance on the Growth Enterprise Market, marking a successful completion of the company’s IPO. The issue price was RMB 23.70 yuan (USD $2.4), and after two days of listing Scitop Bio gained a cumulative increase of 58.4%, bringing its market value to RMB 3.098 billion yuan (USD $440 million).

Scitop Bio’s path to success involves identifying, creating and meeting customer needs. Firstly, its strategic goal has always been to build the best brand of probiotics. Secondly, to meet the new needs of the market, Scitop Bio continues to expand the types of its probiotic products, such as yogurt, lactobacillus drinks, solid drinks and pressed candy. At the same time, Scitop Bio also develops products with targeted efficacy, for special needs of different groups of people such as adults, children, pregnant women, and even animals. (Source: mr-gut.cn)

Comments are closed.